当前位置: 首页 > 详情页

Targeting CIRP and IL-6R-mediated microglial inflammation to improve outcomes in intracerebral hemorrhage

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Neurophysiology and Neuropharmacology, Institute of Special Environmental Medicine and Co-innovation Center of Neuroregeneration, Nantong University, 9 Seyuan Road, Nantong, Jiangsu 226019, China [2]Beijing Institute of Brain Disorders, No. 10 Xitoutiao, Beijing 100069, China. [3]Department of Neurosurgery, Zhengzhou University People's Hospital (Henan Provincial People's Hospital), 7 Weiwu Road, Zhengzhou, Henan 450000, China. [4]Department of Emergency, Affiliated Hospital of Nantong University, Nantong 226001, China. [5]Department of Neurology, Affiliated Hospital of Nantong University, Nantong 226001, China. [6]Department of Neurology, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Beijing 100053, China.
出处:
ISSN:

关键词: Intracerebral hemorrhage Cold-inducible RNA-binding proteins Neuroinflammation Microglial polarization Tat peptides

摘要:
Cold-inducible RNA-binding protein (CIRP) is an emerging inflammatory mediator implicated in neuronal injury following intracerebral hemorrhage (ICH). However, the underlying mechanisms by which CIRP contributes to neuroinflammation remain unclear.To investigate the role of neuron-derived CIRP in activating microglial inflammation via IL-6 receptor (IL-6R) signaling after ICH and to evaluate the therapeutic potential of targeting CIRP and IL-6R using a designed peptide inhibitor.Single-cell RNA sequencing was performed to identify key genes and pathways involved in microglial responses post-ICH. A peptide inhibitor, Tat-CIRP-CMA (TCC), was designed to target CIRP and IL-6R and tested in both in vitro (oxygen-glucose deprivation model) and in vivo (rat ICH model) systems. The effects of TCC on neuronal CIRP release, microglial activation, inflammation, and phagocytic function were assessed. A microglia-specific IL-6Rα knockout mouse model was used to further validate the functional relevance of the IL-6R/ signal transducer and activator of transcription 3 (STAT3) pathway. Clinical analysis of human ICH patients evaluated the correlation between peripheral CIRP expression and infarct volume.Neuron-derived CIRP activates microglia through IL-6R and downstream STAT3 signaling, driving pro-inflammatory responses in ICH. TCC treatment significantly reduced neuronal CIRP release, suppressed microglial activation, and decreased inflammatory cytokine levels. TCC inhibited the IL-6R /STAT3 pathway and enhanced microglial phagocytosis of red blood cells. Microglia-specific IL-6Rα deletion mirrored the anti-inflammatory and neuroprotective effects observed with TCC, reducing hematoma volume and improving sensory and behavioral outcomes. In human ICH patients, elevated peripheral CIRP expression positively correlated with infarct volume, supporting its value as a biomarker for ICH severity and prognosis.CIRP plays a pivotal role in post-ICH neuroinflammation by acting on IL-6R in microglia. The TCC peptide inhibitor effectively reduces CIRP-IL-6R mediated inflammation and supports neuroprotection. CIRP represents a promising therapeutic target and biomarker for ICH.Copyright © 2025 The Author(s). Published by Elsevier B.V. All rights reserved.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 1 区 综合性期刊
小类 | 1 区 综合性期刊
最新[2025]版:
大类 | 1 区 综合性期刊
小类 | 1 区 综合性期刊
第一作者:
第一作者机构: [1]Department of Neurophysiology and Neuropharmacology, Institute of Special Environmental Medicine and Co-innovation Center of Neuroregeneration, Nantong University, 9 Seyuan Road, Nantong, Jiangsu 226019, China [2]Beijing Institute of Brain Disorders, No. 10 Xitoutiao, Beijing 100069, China.
共同第一作者:
通讯作者:
通讯机构: [2]Beijing Institute of Brain Disorders, No. 10 Xitoutiao, Beijing 100069, China. [6]Department of Neurology, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Beijing 100053, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:18261 今日访问量:1 总访问量:1004 更新日期:2025-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院